Evaluation of Prognostic Modification in COVID-19 Patients in Early Intervention Treatment

NCT04673214 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

114

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19

Interventions

DRUG: Azithromycin / Ivermectin / Ribaroxaban / Paracetamol
DRUG: Azithromycin / Ribaroxaban / Paracetamol

Sponsor

Gilberto Cruz Arteaga

Collaborators

[object Object]